Navigation Links
MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial

ng (T2)) cranial MRI lesions (the primary endpoint of the trial) and other MRI-related, exacerbation and disability-related endpoints (relapse rate and Expanded Disability Status Scale (EDSS) score) after 12 months of treatment. Eligible patients who elected to continue their participation in the trial after 12 months of treatment will continue to receive treatment and will be assessed at months 13, 14, 16, 18, 20, 22 and 24 of the trial; patients who received placebo during the first 12 months of the trial were randomized to receive either 30 or 60 mg of MN-166 per day (double-blind maintained) during the second 12 months of the trial.

About Multiple Sclerosis and MN-166

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS), affecting approximately 250,000 - 350,000 people in the U.S. The most obvious effect of MS is the progressive loss of muscle control, but multiple brain and CNS functions are also affected. There is no cure for the disease. Relapsing-remitting MS (RRMS), which is the most common type of the disease, affects approximately 65% of MS patients according to a Cognos study published by Decision Resources, Inc. Most patients with RRMS eventually progress to the secondary progressive (SPMS) form of the disease.

MN-166 is a novel, orally administered compound being evaluated for the treatment of MS. MN-166 inhibits leukotriene activity, phosphodiesterases and nitric oxide synthase, all inflammatory mechanisms known to be involved in MS. MN-166 may also suppress the production of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and may enhance the production of the anti-inflammatory cytokines (IL-4, IL-10). In two pilot clinical trials sponsored by academic investigators in Japan, MN-166 was found to have certain beneficial effects with respect to the treatment of MS.

MediciNova acquired an exclusive, worldwide (excluding Japan, China, Taiwan and South Korea), sublicensable licens
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/31/2014)... COLORADO SPRINGS, Colo. , July 31, 2014 ... Company specializing in cannabis formulation-based drug development and ... has commenced production of multiple strains of cannabis ... scientific research to select the best strains for ... to bring the cannabis formulations to market for ...
(Date:7/31/2014)... , July 31, 2014 For the ... can watch the implantation of the SynCardia temporary Total ... and matching video posted on the Journal of Visualized ... and read the paper on the SynCardia Total Artificial ... 16-minute video accompanies "Implantation of the SynCardia Total Artificial ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... , NEW ... new market research report is available in its ... Global Market Review , http://www.reportlinker.com/p0164324/Holter-Monitoring-Systems---A-Global-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... is extremely beneficial for cardiac patients. High-risk patients ...
... , BIRMINGHAM, ... University of Alabama at Birmingham (UAB), and Southern Research Institute ... their collective innovation and enabling technologies in the areas of ... U.S.-India arbitraged and leveraged partnership that will accelerate the development ...
Cached Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Holter Monitoring Systems - A Global Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
(Date:7/31/2014)... 2014 A program for anyone looking ... the University of Colorado Anschutz Health and Wellness ... boot camp and transformation program. , “Extreme Weight ... Eyeworks USA, is an evidenced-based program inspired by the ... Eyeworks USA. This season, the show has participants spending ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Current residents ... abuse treatment program in Flagstaff, AZ, learn to kayak ... of equipment and paddle strokes in preparation for next ... , "I think that [the kayaking course] teaches [residents] ... they struggle with in their early part of their ...
(Date:7/31/2014)... July 31, 2014 Parker Waichman, LLP, ... tam cases, comments that whistleblowers are a critical component ... employer activities that may cause harm to consumers and ... National Whistleblower Appreciation Day. , According to a 2013 ... the Senate declared "National Whistleblower Appreciation Day" on July ...
(Date:7/31/2014)... To further educate the public, The ... following safety information regarding leaving children in hot vehicles: ... deadly consequences. Because a child’s body can heat up ... leaving children alone in a hot vehicle puts them ... , Statistics of Children Left Alone in a Car ...
Breaking Medicine News(10 mins):Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3Health News:Back2Basics Substance Abuse Residents Take Kayaking Class for the First Time 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 2Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 3
... to announce the opening of its first healthcare center ... The new center opened,January 23, 2008. A second center ... Dr. Thomas Gibbons, the Midlands and Pee Dee ... excited to provide convenient,urgent care, family care and occupational ...
... Smaller Hospitals; Communities Come Out in Droves ... Jan. 25 Drum roll, please... The winner,of ... Memorial Hospital in,Lockport, N.Y. The hospital is the ... of Siemens, latest developments in magnetic resonance,imaging (MRI) ...
... Arizona, raises MDS capacity in the ... Phoenix-area to 420 total beds, KING ... ), a leading provider of innovative drug discovery,and development solutions, has ... I facility in nearby Tempe, Arizona. The $25,million facility more than ...
... Veterinarians,recently took to Capitol Hill to help ... its food supply -- and its capacity for ... needs federal support., Dr. W. Ron DeHaven, ... was one of four veterinarians to testify January ...
... GERMANTOWN, Md., Jan. 25 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... and commercializing novel anti-infective products, today,announced that it ... for the private placement of 8,750,000 shares of,its ... also includes,five-year warrants to purchase 3,500,000 shares of ...
... 25 Arthur Patrick Partners, a Las Vegas,private ... definitive agreement,to acquire a majority stake in Fit ... e-commerce site FitFuel.com, a retailer of healthy living,products. ... Fuel-branded,media-capable "healthy" vending machines, and has recently introduced ...
Cached Medicine News:Health News:UCI Medical Affiliates Inc. Opens New Doctors Care Center in Florence 2Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 2Health News:...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National 'Win an MRI' Contest 3Health News:MDS Pharma Services Opens Largest Phase I Clinic on U.S. West Coast 2Health News:Calling for More Veterinarians 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 3Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 4Health News:Arthur Patrick Partners Acquires Fit Fuel, LLC 2
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Titanium. 0.12 mm 1 x 2 teeth with 6 mm platform and 2.0 mm angled tips. Flat serrated handle, dull finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Narrow 4 mm long smooth platform. Serrated handle with polished finish....
Medicine Products: